Prof. Dr. Markus Neurath

Lehrstuhl für Innere Medizin I (Medizin 1)

IL-36 in chronic inflammation and cancer (2020) Neurath M Journal article, Review article How Much Liver Tissue Is Required for Sufficient Histological Staging in Patients with Primary Biliary Cholangitis? (2020) Vetter M, Kremer A, Agaimy A, Pfeifer L, Neurath M, Zopf S, Siebler J Journal article Mild COVID-19 Symptoms in an Infliximab-Treated Ulcerative Colitis Patient: Can Ongoing Anti-TNF Therapy Protect against the Viral Hyperinflammatory Response and Avoid Aggravated Outcomes? (2020) Abdullah A, Neurath M, Atreya R Journal article Covid-19 and immunomodulation in IBD (2020) Neurath M Journal article, Review article COVID-19: risk for cytokine targeting in chronic inflammatory diseases? (2020) Schett G, Sticherling M, Neurath M Journal article An IFN-STAT1-MLKL axis drives programmed necrosis of Paneth cells in Crohn's ileitis (2020) Hartmann L, Siegmund B, Weidinger C, Becker C, Neurath M, Günther C Conference contribution Efficacy, safety, and pharmacokinetics after switching from infliximab originator to biosimilar SB2 in inflammatory bowel disease patients: A long-term observational, prospective cohort study (2020) Fischer S, Mesfin SE, Klenske E, Schmitt H, Vitali F, Hirschmann S, Ramming A, et al. Conference contribution Dose-dependent differential effects of vedolizumab therapy on adhesion of regulatory and effector T cells (2020) Becker E, Wiendl M, Schulz-Kuhnt A, Atreya I, Atreya R, Neurath M, Zundler S Conference contribution Use of Fluorescent Dyes in Endoscopy and Diagnostic Investigation (2020) Hoffman A, Atreya R, Rath T, Neurath M Journal article, Review article Nanoparticles in Gastrooncology (2020) Jefremow A, Neurath M Journal article, Review article